Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Epirus Biopharmaceuticals Inc EPRSQ

Healthcare Biotechnology
EPIRUS Biopharmaceuticals, Inc. is in bankruptcy.

Recent & Breaking News (OTCPK:EPRSQ)

Stocks Hitting 52-Week Lows

Benzinga.com  July 5, 2016

Stocks Hitting 52-Week Highs

Benzinga.com  July 5, 2016

EPIRUS Announces Reprioritization of Pipeline to Solely Focus on Biosimilars to Treat Rare Diseases and Key Leadership Changes

GlobeNewswire May 9, 2016

MannKind Corporation Reports 2016 First Quarter Financial Results

GlobeNewswire May 9, 2016

EPIRUS Biopharmaceuticals Reports Fourth Quarter and Fiscal Year 2015 Financial Results and Provides Business Update

GlobeNewswire March 15, 2016

EPIRUS Biopharmaceuticals to Release Fourth Quarter and Fiscal Year 2015 Financial Results and Provide Business Update

GlobeNewswire March 1, 2016

EPIRUS Biopharmaceuticals Initiates Pivotal Global Phase 3 Clinical Study for BOW015 (Infliximab Biosimilar)

GlobeNewswire February 9, 2016

EPIRUS Biopharmaceuticals to Participate in Bloomberg Intelligence Healthcare Event on February 12

GlobeNewswire February 5, 2016

EPIRUS Biopharmaceuticals to Present at LEERINK Partners 5th Annual Global Healthcare Conference

GlobeNewswire February 3, 2016

Volatility Creates Opportunity, Insights on Price Data - Research on Delta Apparel, Epirus Biopharmaceuticals, Shiloh Industries, and LifeVantage

Accesswire December 1, 2015

EPIRUS Biopharmaceuticals Provides Clinical Program Update on BOW015 (Infliximab Biosimilar)

GlobeNewswire November 16, 2015

EPIRUS Biopharmaceuticals Reports Third Quarter 2015 Financial Results & Provides Business Update

GlobeNewswire November 16, 2015

EPIRUS Biopharmaceuticals Reschedules Its Third Quarter 2015 Financial Results Conference Call and Webcast

GlobeNewswire November 11, 2015

EPIRUS Biopharmaceuticals Appoints Industry Veteran Vincent E. Aurentz as Chief Business Officer

GlobeNewswire November 10, 2015

EPIRUS Biopharmaceuticals Joins Biosimilars Forum to Help Educate Patients and Healthcare Providers on Importance of Biosimilars

GlobeNewswire November 5, 2015

EPIRUS Biopharmaceuticals to Release Third Quarter 2015 Financial Results and Provide Business Update

GlobeNewswire October 29, 2015

EPIRUS Biopharmaceuticals Expands Biosimilar Pipeline and Capabilities Through Acquisition of Bioceros

GlobeNewswire September 9, 2015

EPIRUS Biopharmaceuticals Reports Second Quarter 2015 Financial Results

GlobeNewswire August 7, 2015

EPIRUS Biopharmaceuticals Reports Second Quarter 2015 Financial Results

GlobeNewswire August 7, 2015

EPIRUS Biopharmaceuticals to Present at Wedbush PacGrow Healthcare Conference

GlobeNewswire August 4, 2015